The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer

Abstract

T he rationale behind updating the interdisciplinary S3 guideline (1) is the high epidemiological relevance of breast cancer and the associated relevance for routine health care (Figure 1). The need to update the guideline also arises from the emergence of new scientific knowledge. The recommendations are addressed to all physicians and members of professional groups involved in the health care of individuals undergoing screening and breast cancer patients (gynecologists, general practitioners , radiologists, pathologists, radio-oncologists, medical oncologists, psycho-oncologists, physiotherapists , nursing staff, etc.), as well as all women with breast cancer and their relatives. Other target groups include: • Scientific medical societies and professional organizations • Women's interest groups (women's health organizations , patient and self-help organizations) • Quality assurance bodies at German federal and state level • Health policy institutions and decision-makers at German federal and state level • Contract managers for disease management programs and integrated care contracts • Cost bearers, and • The public, in order to ensure they are provided with information on an evidence-based approach to breast cancer.